top of page

Palbace ( known as IBRANCE in other parts of the world) or palbociclib by Pfizer is a cancer drug that interferes with the growth and spread of cancer cells in the body.

Palbace is generally used in combination with letrozole or fulvestrant (Faslodex) for treating certain types of advanced breast cancer in postmenopausal women. It is also given in combination with another cancer medicine, either letrozole (Femara) or fulvestrant (Faslodex).

Palbace is a renamed version of the drug Ibrance for the Indian market. It is approved by the US Food and Drug Administration (FDA). In clinical studies, palbociclib appeared to improve survival time of patients.

Palbace comes in capsule form in 125 mg dose. 1 pack has 21 capsules.



bottom of page